Restricted accessResearch articleFirst published online 2013-08
Mycobacterium tuberculosis PE_PGRS17 Promotes the Death of Host Cell and Cytokines Secretion via Erk Kinase Accompanying with Enhanced Survival of Recombinant Mycobacterium smegmatis
Tuberculosis (TB) remains a serious threat to global public health, largely due to the successful manipulation of the host immunity by its etiological agent Mycobacterium tuberculosis. The PE_PGRS protein family of M. tuberculosis might be a contributing factor. To investigate the roles of PE_PGRS17, the gene of PE_PGRS 17 was expressed in nonpathogenic fast growing Mycobacterium smegmatis. We found that the recombinant strain survives better than the control in macrophage cultures, accompanied by more host cell death and a marked higher secretion of tumor necrosis factor-alpha by a recombinant strain compared with control. Blocking the action of Erk kinase by an inhibitor can abolish the above effects. In brief, our data showed that PE_PGRS 17 might facilitate pathogen survival and disserve the host cell via remodeling the macrophages immune niche largely consisting of inflammatory cytokines. This furnishes a novel insight into the immune role of this mycobacterium unique gene family.
Get full access to this article
View all access options for this article.
References
1.
BansalK, ElluruSR, NarayanaY, ChaturvediR, PatilSA, KaveriSV, BayryJ, BalajiKN. 2010. PE_PGRS antigens of Mycobacterium tuberculosis induce maturation and activation of human dendritic cells. J Immunol, 184,7:3495–3504.
2.
BanuS, HonoreN, Saint-JoanisB, PhilpottD, PrevostMC, ColeST. 2002. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?Mol Microbiol, 44,1:9–19.
3.
BasuS, PathakSK, BanerjeeA, PathakS, BhattacharyyaA, YangZ, TalaricoS, KunduM, BasuJ. 2006. Execution of Macrophage Apoptosis by PE_PGRS33 of Mycobacterium tuberculosis is mediated by toll-like receptor 2-dependent release of tumor necrosis factor. J f Biol Chem, 282,2:1039–1050.
4.
BeharSM, DivangahiM, RemoldHG. 2010. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?Nat Rev Microbiol, 8,9:668–674.
5.
BosqueF, MilonG, ValderramaL, SaraviaNG. 1998. Permissiveness of human monocytes and monocyte-derived macrophages to infection by promastigotes of Leishmania (Viannia) panamensis. J Parasitol, 84,6:1250–1256.
6.
BrennanMJ, DeloguG. 2002. The PE multigene family: a “molecular mantra” for mycobacteria. Trends Microbiol, 10,5:246–249.
7.
BrennanMJ, DeloguG, ChenY, BardarovS, KriakovJ, AlaviM, JacobsWRJr.2001. Evidence that mycobacterial PE_PGRS proteins are cell surface constituents that influence interactions with other cells. Infect Immun, 69,12:7326–7333.
8.
DebC, DanielJ, SirakovaTD, AbomoelakB, DubeyVS, KolattukudyPE. 2006. A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis. J Biol Chem, 281,7:3866–3875.
9.
DeloguG, PuscedduC, BuaA, FaddaG, BrennanMJ, ZanettiS. 2004. Rv1818c-encoded PE_PGRS protein of Mycobacterium tuberculosis is surface exposed and influences bacterial cell structure. Mol Microbiol, 52,3:725–733.
10.
DheenadhayalanV, DeloguG, BrennanMJ. 2006. Expression of the PE_PGRS 33 protein in Mycobacterium smegmatis triggers necrosis in macrophages and enhanced mycobacterial survival. Microbes Infect, 8,1:262–272.
11.
FentonMJ, VermeulenMW. 1996. Immunopathology of tuberculosis: roles of macrophages and monocytes. Infect Immun, 64,3:683–690.
12.
HuangY, WangY, BaiY, WangZG, YangL, ZhaoD. 2010. Expression of PE_PGRS 62 protein in Mycobacterium smegmatis decrease mRNA expression of proinflammatory cytokines IL-1beta, IL-6 in macrophages. Mol Cell Biochem, 340,1–2:223–229.
13.
JainSK, Paul-SatyaseelaM, LamichhaneG, KimKS, BishaiWR. 2006. Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis. J Infect Dis, 193,9:1287–1295.
14.
LeeSB, SchoreyJS. 2005. Activation and mitogen-activated protein kinase regulation of transcription factors Ets and NF-kappaB in Mycobacterium-infected macrophages and role of these factors in tumor necrosis factor alpha and nitric oxide synthase 2 promoter function. Infect Immun, 73,10:6499–6507.
15.
NarayanaY, JoshiB, KatochVM, MishraKC, BalajiKN. 2007. Differential B-cell responses are induced by Mycobacterium tuberculosis PE antigens Rv1169c, Rv0978c, and Rv1818c. Clin Vaccine Immunol, 14,10:1334–1341.
PostFA, MancaC, NeyrollesO, RyffelB, YoungDB, KaplanG. 2001. Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro. Infect Immun, 69,3:1433–1439.
18.
RaviglioneMC, SniderDEJr., KochiA. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA, 273,3:220–226.
19.
RedpathS, GhazalP, GascoigneNR. 2001. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol, 9,2:86–92.
20.
RoachDR, BeanAG, DemangelC, FranceMP, BriscoeH, BrittonWJ. 2002. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol, 168,9:4620–4627.
21.
RoachSK, SchoreyJS. 2002. Differential regulation of the mitogen-activated protein kinases by pathogenic and nonpathogenic mycobacteria. Infect Immun, 70,6:3040–3052.
22.
SanoC, SatoK, ShimizuT, KajitaniH, KawauchiH, TomiokaH. 1999. The modulating effects of proinflammatory cytokines interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha), and immunoregulating cytokines IL-10 and transforming growth factor-beta (TGF-beta), on anti-microbial activity of murine peritoneal macrophages against Mycobacterium avium-intracellulare complex. Clin Exp Immunol, 115,3:435–442.
23.
SchnappingerD, EhrtS, VoskuilMI, LiuY, ManganJA, MonahanIM, DolganovG, EfronB, ButcherPD, NathanC, SchoolnikGK. 2003. Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med, 198,5:693–704.
24.
ShinnickTM, KingCH, QuinnFD. 1995. Molecular biology, virulence, and pathogenicity of mycobacteria. Am J Med Sci, 309,2:92–98.
25.
SinghPP, ParraM, CadieuxN, BrennanMJ. 2008. A comparative study of host response to three Mycobacterium tuberculosis PE_PGRS proteins. Microbiology, 154,Pt 11:3469–3479.
26.
SnapperSB, MeltonRE, MustafaS, KieserT, JacobsWRJr.1990. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol, 4,11:1911–1919.
27.
SongCH, LeeJS, KimHJ, ParkJK, PaikTH, JoEK. 2003. Interleukin-8 is differentially expressed by human-derived monocytic cell line U937 infected with Mycobacterium tuberculosis H37Rv and Mycobacterium marinum. Infect Immun, 71,10:5480–5487.
28.
StengerS. 2005. Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann Rheum Dis, 64,Suppl.4:iv24–iv28.
29.
TalaricoS, CaveMD, FoxmanB, MarrsCF, ZhangL, BatesJH, YangZ. 2007. Association of Mycobacterium tuberculosis PE PGRS33 polymorphism with clinical and epidemiological characteristics. Tuberculosis (Edinb), 87,4:338–346.
30.
TianC, Jian-pingX. 2010. Roles of PE_PGRS family in Mycobacterium tuberculosis pathogenesis and novel measures against tuberculosis. Microbial Pathogenesis, 49,6:311–314.
31.
WeiJ, DahlJL, MoulderJW, RobertsEA, O'GaoraP, YoungDB, FriedmanRL. 2000. Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages. J Bacteriol, 182,2:377–384.
